By NewsDesk  @infectiousdiseasenews

In late December 2019, antibiotic development and commercialization company, Melinta Therapeutics, Inc. initiated a voluntary Chapter 11 process to effectuate restructuring transaction while continuing normal-course operations.

This caused a ripple effect of concern in the medical and public community. This followed just six months after Achaogen filed for bankruptcy.

In this video, I take a look at this important issue, some experts thoughts on how to address it and a Senate bill that hasn’t gone far in 6 months.

Outbreak News Merchandise

African swine fever in Asia

Infectious disease news brief: Monkeypox in Singapore

1 million STD cases daily across the globe

Nipah virus confirmed in Kerala, India

Congenital syphilis on the rise in the US: Tragic and Preventable!


PLAGUE in China: An update and review

SAMOA MEASLES OUTBREAK: ‘This epidemic has not yet peaked’

Dengue: ‘The rise in outbreaks this year is a wake-up call’

Measles in Japan 2019: Highest number of cases in years